VIVOTEK INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 139 TWD | 0.00% |
|
-0.71% | -14.72% |
| 05-14 | Vivotek Introduces Ai Entry-Tier 9383-Series Network Camera for All-Around Ai Solution | CI |
| 04-29 | Vivotek Inc. Announces Board and Committee Changes | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- With a 2024 P/E ratio at 27.74 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Sector: Communications & Networking
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -14.72% | 369M | - | ||
| -10.60% | 39.86B | A- | ||
| -9.50% | 10.03B | B | ||
| +12.46% | 6.91B | C+ | ||
| -15.50% | 7.03B | A- | ||
| +3.13% | 2.83B | B | ||
| +48.96% | 1.88B | D | ||
| +10.26% | 1.75B | - | C+ | |
| -4.83% | 1.39B | C- | ||
| +6.68% | 1.4B | - |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 3454 Stock
- Ratings Vivotek Inc.
